NIAID Monovalent Inactivated Influenza A/H5N8 Clinical Trials

In The NewsMay 03, 2024

Cross-reactive Hemagglutination Inhibition (HAI) Antibodies to Emerging Strains

H5N8 IIV-like vaccine cross-reactive antibody results against A/bovine H5N1.

You may also view these results as a PDF version.


Please Note: This data was shared with the relevant U.S. federal government agencies responsible for wider testing, surveillance, and response efforts associated with the H5N1 outbreak in U.S. dairy cattle.